You are here

Medigene

Medigene axes staff and refocuses its TCR pipeline

Pharmaphorum

Tue, 11/26/24 - 09:42 am

T-cell receptors

Immunocore is the latest to nab a private placement, securing $140M to pursue more TCR R&D

Endpoints

Mon, 07/18/22 - 07:13 pm

BioNTech and Medigene team up on T cell immunotherapy

Biopharma Reporter

Tue, 02/22/22 - 11:10 pm

T-cell immunotherapy

Bluebird widens hunt for TCR therapies in revised Medigene deal

Biopharma Dive

Mon, 05/14/18 - 10:58 pm